← Eichor
Study identifier: NCT07365579 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Design and Feasibility of an SMS-based Safety Planning Intervention

Condition: Suicidal Ideation and Behavior  ·  Sponsor: Northwestern University

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 24 Years
Healthy volunteersNo

About this study

This study is testing whether it is feasible to run a larger randomized controlled trial and whether an automated text messaging program is acceptable to young adults who have suicidal thoughts. The program is designed to help participants create and use a safety plan, which is a personalized list of warning signs, coping strategies, supportive people, professional resources, ways to make their environment safer, and reasons for living. After joining and completing an initial survey, participants are randomly assigned by a computer to one of two groups. One group starts right away with the interactive safety planning text program. The other group first receives simple text messages with 24/7 crisis resources and then, after four weeks, also receives the interactive safety planning program. Participants use the text program for about four weeks and complete online surveys at the start and again over a total period of 24 weeks.

This description comes directly from the study's public registry record.

Talk to the study team

Jonah Meyerhoff, PhD  ·  312-503-1232  ·  jonah.meyerhoff@northwestern.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Northwestern UniversityChicago, Illinois, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07365579